Hong Kong Life Sciences Stock News

Sunac China Holdings (SEHK:1918) reported its half-year 2026 results, with sales of CNY 16,349.26 million compared with CNY 19,987.6 million a year earlier and a reduced net loss. At a latest share price of HK$0.64, Sunac China Holdings has seen a 1 day share price return of 14.29%. However, the share price return year to date is down 50.00% and the 1 year total shareholder return is down 59.75%, pointing to pressure that remains despite the recent bounce around the earnings update. Spot list...

Dividend and Earnings Announcement Draw Focus to Shanghai Industrial Holdings Shanghai Industrial Holdings (SEHK:363) has put fresh attention on its stock after releasing half year 2026 results alongside an interim dividend of HK$0.42 per share, with payout set for mid October. The company reported sales of HK$8,805.47 million for the six months to 30 June 2026 compared with HK$9,476.03 million a year earlier. Net income was HK$1,057.98 million compared with HK$1,041.8 million, with basic and...

Why First Pacific’s Latest Half Year Earnings Matter For Investors First Pacific (SEHK:142) has drawn fresh attention after reporting half year 2026 results that showed sales of US$5,316.3m alongside net income of US$301.5m, compared with US$5,027.8m and US$391.2m a year earlier. First Pacific’s latest half year results, which showed sales growth alongside lower net income, come with a share price of HK$5.095 and a year-to-date share price return that has fallen 14.66%. The 5-year total...

Laopu Gold earnings jump and interim dividend put income profile in focus Laopu Gold (SEHK:6181) drew fresh attention after reporting higher half year sales and net income for the six months to 30 June 2026, alongside an interim cash dividend of RMB 18.02 per share. The earnings and dividend announcement on 25 August came after a mixed run for Laopu Gold, with the 30 day share price return up 13.44%, but the year to date share price return down 35.95% and the 1 year total shareholder return...

China International Capital (SEHK:3908) reported half year 2026 earnings that caught investor attention, with revenue of CNY 26,047.21m and net income of CNY 8,199.27m compared with the same period a year earlier. Following these results, China International Capital’s share price closed at HK$21.9, with a 1-day share price return of 2.91%. This partly offsets a weaker 7-day share price return of 4.28% and signals some renewed short term interest after the earnings release. Over a longer...

CGN New Energy Holdings (SEHK:1811) has drawn investor focus after reporting lower half year sales and net income, while also declaring an interim dividend, a mix that raises fresh questions about earnings quality and capital returns. At a latest share price of HK$2.125, CGN New Energy Holdings has seen its short-term momentum fade, with a 1-month share price return of a 3.85% decline and a 3-month share price return of a 19.2% decline. In contrast, the 3-year total shareholder return of...

Dividend and earnings event investors are focusing on Sinotruk (Hong Kong) (SEHK:3808) is in focus after reporting half year results to 30 June 2026, alongside an interim cash dividend of HK$1.18 per share, with payment set for 20 November 2026. The record date for the dividend is 17 September 2026 and the ex dividend date is 10 September 2026. These dates are key markers if you are tracking near term income from the stock. At a share price of HK$41.26, Sinotruk (Hong Kong) has delivered a...

Z.AI Co., Ltd. ( HKG:2513 ) shareholders will have a reason to smile today, with the analysts making substantial...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

JD Logistics (SEHK:2618) is back in focus after the company announced that long serving finance executive Hao Wu has resigned as chief financial officer, with experienced insider Henry Jun Mao stepping into the role. Against this backdrop, JD Logistics’ share price has been under pressure, with a 30 day share price return of down 24.98% and a 90 day share price return of down 13.81%, while the 3 year total shareholder return of 8.45% contrasts with a 1 year total shareholder return of down...

NetEase (SEHK:9999) is back in focus after launching its free to play survival game Once Human on PlayStation 5 and Xbox Series X|S, alongside an Isles of Abyss expansion planned for October. Despite the Once Human console launch putting NetEase back in the headlines, the share price tells a mixed story. The 1 day share price return of 3.33% at HK$189.1 contrasts with a year to date share price return that is down 17.35% and a 1 year total shareholder return that is down 7.78%. This is set...

China Mengniu Dairy (SEHK:2319) drew investor focus after reporting half year 2026 results, with sales of CNY 44,794.93 million and net income of CNY 2,371.5 million, followed by its scheduled earnings call. The latest move in China Mengniu Dairy's share price, with a 1-day share price return of 2.76% to HK$18.24, comes after its half year 2026 earnings update and call. The 90-day share price return of 14.79% and year to date share price return of 22.17% point to building momentum despite a...

What Meituan’s Half Year 2026 Results Tell You Meituan (SEHK:3690) released half year 2026 results that combined higher sales with a swing into loss. This mix of revenue growth and weaker profitability is shaping how investors reassess the stock. For the half year to 30 June 2026, Meituan reported sales of CNY 195,681.95 million compared with CNY 177,696.36 million a year earlier. Despite this, the company moved from net income of CNY 10,421.64 million to a net loss of CNY 4,672.49...

China Petroleum & Chemical (SEHK:386) has moved further into low carbon energy by helping launch the Initiative for Cooperation on Low-Carbon Energy Development and joining the International CCUS Technology Innovation Cooperation Organization. China Petroleum & Chemical’s short term momentum has picked up, with a 10.75% 1 month share price return and 11.65% 3 month share price return at a last close of HK$4.79, while a 5 year total shareholder return of 83.23% points to a stronger long term...

Yankuang Energy Group (SEHK:1171) has drawn fresh attention after reporting higher year over year revenue and net income for the first half of 2026, alongside an interim dividend of RMB 0.20 per share. Yankuang Energy Group's recent earnings release, interim dividend declaration and completion of its prior buyback plan come as the share price trades at HK$13.30, with a 1 month share price return of 14.56% but a 3 month share price return that has declined 11.27%. Compare Yankuang Energy...

In late August 2026, BYD Electronic (International) Company Limited reported past-half-year results showing sales of CNY 82,234.2 million, up slightly from CNY 80,605.68 million a year earlier, while net income fell to CNY 426.33 million from CNY 1,729.78 million. The contrast between rising revenue and sharply weaker profitability, with basic earnings per share from continuing operations dropping from CNY 0.77 to CNY 0.19, highlights mounting cost or margin pressures. We will now examine...

Z.AI (SEHK:2513) reported half year 2026 results, with sales of CNY 953.89 million and a net loss of CNY 2,071.33 million, a key update that quickly fed into investor sentiment. At a latest share price of HK$1,075.0, Z.AI has recorded a substantial year-to-date share price return of about 7x. However, the 90‑day share price return is down 17.12%, which indicates that while longer-term momentum has been strong, more recent gains have moderated. Spot opportunities across AI by reviewing the 71...

In recent months, the Asian markets have experienced mixed performances, with technology and AI-related sectors showing resilience amid broader economic uncertainties. As investors navigate this complex landscape, identifying undervalued stocks becomes crucial for those seeking opportunities to capitalize on potential market inefficiencies.

Why Horizon Robotics Stock Is Back On Investors’ Radar Horizon Robotics (SEHK:9660) drew fresh attention after its half year 2026 earnings on 31 August, when the company moved from a loss to net income alongside higher reported sales. Even with the sharp improvement in half year results, Horizon Robotics’ recent share price return has been weak, with the stock at HK$4.37 after a 1 day share price return of 1.51% but a 1 year total shareholder return that is down 51.39%. This suggests...

The launch of OpenAI’s GPT-6 Astra has reset expectations for what enterprise AI software can handle, from code to cyber security. That shift in capability and pricing pressure is already shaping how businesses choose their AI partners, which creates fresh openings and risks for investors. This article unpacks that story and highlights 3 stocks from our Enterprise AI Software Enablers screener that appear particularly exposed to this new phase of the AI race. The stocks below are just a...

Envision Greenwise Holdings (SEHK:1783) has set up a new Board-level strategy committee, effective 28 August 2026. This move places medium to long term development planning under closer oversight for this construction and environmental services group. The new strategy committee arrives after a mixed period for Envision Greenwise Holdings, with the share price up 29.94% year to date but experiencing a 7 day share price return decline of 11.95% and a 30 day share price return decline of 8.16%,...

As the Asian markets navigate a complex landscape marked by resilient economies and evolving investor sentiment, opportunities continue to emerge for those seeking growth potential. Penny stocks, though often seen as a relic of past market eras, remain relevant due to their affordability and potential for significant returns when backed by strong financials. This article explores several standout penny stocks in Asia that exhibit robust fundamentals and may offer intriguing prospects for...

CStone Pharmaceuticals (SEHK:2616) stock is in focus after the company released its 2026 interim update, highlighting fresh CS2009 clinical data, stronger pralsetinib uptake, and progress toward global Phase III trials. At a latest share price of HK$6.18, CStone Pharmaceuticals has seen a 1 month share price return of 42.07% and a 90 day share price return of 23.35%. However, the 1 year total shareholder return declined 48.93%, which hints that recent clinical and interim results have...

Horizon Robotics ( HKG:9660 ) just released its latest half-year report and things are not looking great. Horizon...